Hypersensitivity of ATM-defective cells to IR and the critical function of the ATR pathway for the survival of tumor cells has led to considerable interest in ATM and ATR as therapeutic targets for cancer therapy [93,98,99]. The gene discussed is ATR; the disease is neoplasm.